ICON Web & News
Virtual Journal
Everything
Resources
Virtual Journal
Analyze Database
GoodNanoGuide
ICON Reports
ICON Backgrounders
Glossary
Policy Reports
Ratings Comment
Guidelines
Links
Quick Search:
Keywords:
Search:
Search Using OECD Database
Details
Return to Previous Page
Addition or Correction
Title:
In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles
Date:
2/2013
Link to Journal Abstract
Abstract:
Gold nanoparticles are emerging as promising materials from which to construct nanoscale therapeutics and therapeutic delivery systems. However, animal studies have shown that gold nanoparticles modified with certain thiol monolayers such as tiopronin can cause renal complications and morbidity. Although these effects may be eliminated by coadsorbing small amounts of polyethylene glycol (PEG) onto the nanoparticle surface, PEG can also lower cellular internalization efficiency and binding interactions with protein disease targets, significantly reducing the potential for using gold nanoparticles as therapeutics. Using ICP-MS analysis of blood, urine, and several organs, we show in this article that glutathione-coated gold nanoparticles (1.2 nm ± 0.9 nm) cause no morbidity at any concentration up to and including 60 ìM and target primary organs although providing gradual dissipation and clearance over time. This study suggests that glutathione may be an attractive alternative to PEG in the design of gold nanoparticle therapeutics.
Non-technical Summary:
This study describes the utility and toxicity of glutathione coated gold nanoparticles in comparison to PEGylated counterparts that are commonly used to increase “Stealth” properties and lower cytotoxicity.
Content Emphasis
Peer Reviewed Journal Article
Exposure Or Hazard Target
Mammalian
Exposure Pathway
Other/Unspecified
Method Of Study
In Vivo
Paper Type
Hazard
Particle Type
Metal
Production Method
Engineered
Risk Exposure Group
General Population
Target Audience
Technical Research
Citation:
Nanomedicine: Nanotechnology, Biology and Medicine, 9(2): 257-263 (February 2013)
Publication:
Nanomedicine: Nanotechnology, Biology and Medicine
Author:
Simpson CA, Salleng KJ, Cliffel DE, Feldheim DL
Volume:
9
Number:
2
Pages:
257-263
Last updated on March 6, 2013
Permalink
Join Us
|
About
|
Newsroom
|
Working Groups
|
Projects
|
Resources
|
Virtual Journal
|
Events
|
Logout
This work is supported in part by the Nanoscale Science and Engineering Initiative of the National Science Foundation
under NSF Award Number EEC-0118007.
Why Join Us?
Mission and Strategy
Background
Organization
Sponsors
Participants
Contact Us
ICON Releases
News
Media Alert
RSS
Governance
Knowledge Base
Best Practices
Communications
Virtual Journal
Analyze Database
Good Nano Guide
ICON Reports
ICON Backgrounders
Glossary
Policy Reports
Links
Council Events
Other Events
Virtual Journal
Analyze Database
The GoodNanoGuide
Nano EHS Research Needs
Current Practices Survey